Breaking new ground in medical and clinical services
Investing in a brighter future
Pioneering developments by our scientific and clinical teams enable us to constantly improve our services and patient outcomes.
Producing platelets from stem cells
Platelet transfusions are used to prevent serious bleeding complications for patients with blood diseases and are sometimes needed after childbirth or surgery.
We are dependent on platelets sourced from blood donors - and as platelets have a short shelf-life, stock management can be an issue. We are working on a process for producing platelets from stem cells as an alternative to donor derived platelets.
World-first blood donor study
INTERVAL is a ground-breaking study to find out the optimum interval between donations for different donors to safely give blood.
The study is the first of its kind and is set up in collaboration with the Universities of Cambridge and Oxford. We are gathering evidence from 50,000 donors and investigating whether donation intervals should be tailored to donors by age, gender, genetic profile and other characteristics. The results will help us improve donor safety and could shape the future of blood donation nationally and internationally.